INTERNATIONAL PATENT: EISAI R&D MANAGEMENT CO., LTD. FILES APPLICATION FOR "ANTI-CD73 ANTIBODIES, CONJUGATES AND METHODS OF USE"

GENEVA, March 4 -- EISAI R&D MANAGEMENT CO., LTD. (6-10 Koishikawa, 4-chome, Bunkyo-kuTokyo, 112-8088) filed a patent application (PCT/US2025/042857) for "ANTI-CD73 ANTIBODIES, CONJUGATES, AND METHODS OF USE" on Aug 20, 2025. With publication no. WO/2026/044039, the details related to the patent application was published on Feb 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ARAI, Kenzo (c/o Eisai Co., Ltd. Tsukuba Research Laboratories5-1-3 TokodaiTsukuba-shi, Ibaraki 3002635), CHENG, Xin (c/o Eisai Inc.200 Metro BoulevardNutley, New Jersey 07110), FURUUCHI, Keiji (c/o Eisai Inc.200 Met...